Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
Clinical trial NCT04108377 · TERMINATED
Trial details
- NCT number
- NCT04108377
- Sponsor
- University of California, Davis
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2022-12-11
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.